Drug Type Chemical drugs |
Synonyms |
Mechanism Aurora A inhibitors(Serine/threonine-protein kinase Aurora-A inhibitors), HSP70 heat-shock proteins inhibitors(HSP70 heat-shock proteins inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostate Neuroendocrine Carcinoma | Preclinical | US | 09 Apr 2024 |